Decreasing Health Care Spending Through Market Competition-A Case for the Rapid Adoption of Adalimumab Biosimilars. uri icon

Overview

publication date

  • June 1, 2020

Research

keywords

  • Biosimilar Pharmaceuticals

Identity

Scopus Document Identifier

  • 85082412698

Digital Object Identifier (DOI)

  • 10.1001/jamainternmed.2020.0331

PubMed ID

  • 32227131

Additional Document Info

volume

  • 180

issue

  • 6